Frequently Asked Questions about the ECOG Clinical Trial for
Patients with Stage II Colon Cancer (E5202)
Follow the link below to view the handout answering frequently asked
questions about the E5202 ECOG Clinical Trial for Patients with Stage II Colon Cancer. This is a "A Randomized Phase II Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers".
The document is in Adobe Acrobat format. If you do not already
have Adobe Acrobat Reader running on your computer you can
download this software free of charge from the Adobe web site.
How to contact ECOG
All contents copyright © 2001 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: September 26, 2006
